Integrated evidence planning (IEP) offers a comprehensive framework that harnesses various data sources, scientific methodologies, and cross-functional expertise throughout a product's life cycle, effectively delivering crucial insights into its benefits, safety, and value. Our webinar delved into the functional and operational dimensions of IEP, elucidating its rationale and myriad benefits. The panelists explored the journey of IEP and provided valuable insights into potential barriers associated with IEP and strategies to surmount them. Additionally, they explained operational aspects, including the development, implementation, and optimization of IEP systems.
In this webinar, industry leaders Chris Blanchette, Ph.D. from Novo Nordisk and Shibani Pokras from GSK along with Axtria‘s Principal and HEOR/RWE Practice lead, Won Chan Lee, Ph.D. discussed: